| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 508.845 | 432.577 | 399.474 | 385.377 | 119.399 | 15.426 | 18.319 | 19.165 | 18.082 | 20.055 |
| Total Income - EUR | 509.287 | 451.648 | 418.336 | 403.546 | 464.841 | 15.451 | 18.328 | 19.236 | 18.082 | 20.055 |
| Total Expenses - EUR | 462.242 | 413.131 | 402.548 | 394.707 | 134.715 | 15.743 | 18.114 | 19.294 | 17.522 | 18.704 |
| Gross Profit/Loss - EUR | 47.045 | 38.517 | 15.788 | 8.839 | 330.126 | -292 | 214 | -58 | 560 | 1.351 |
| Net Profit/Loss - EUR | 38.926 | 32.509 | 11.609 | 4.806 | 325.477 | -436 | 43 | -249 | 383 | 1.155 |
| Employees | 7 | 7 | 8 | 8 | 3 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ella-Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.817 | 34.869 | 33.323 | 31.214 | 29.155 | 27.224 | 25.272 | 24.015 | 22.841 | 21.766 |
| Current Assets | 167.719 | 126.338 | 117.558 | 100.681 | 422.447 | 53.312 | 7.402 | 5.808 | 4.930 | 3.519 |
| Inventories | 52.232 | 37.057 | 30.477 | 19.018 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 73.403 | 34.706 | 72.568 | 79.431 | 335.807 | 280 | 602 | 716 | 498 | 500 |
| Cash | 42.084 | 54.575 | 14.512 | 2.232 | 86.640 | 53.032 | 6.800 | 5.092 | 4.432 | 3.019 |
| Shareholders Funds | 88.043 | 68.802 | 49.275 | 45.371 | 358.878 | 22.367 | 21.914 | 21.732 | 22.050 | 23.081 |
| Social Capital | 324 | 320 | 315 | 309 | 303 | 297 | 291 | 292 | 291 | 289 |
| Debts | 116.494 | 92.404 | 101.606 | 86.523 | 92.724 | 58.170 | 10.761 | 8.091 | 5.721 | 2.204 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Ella-Pharm Srl